Advertisement

Topics

ERA-NET PathoGenoMics Company Profile

13:54 EDT 26th September 2017 | BioPortfolio

Pathogen infections are among the leading causes for disease and mortality throughout the globe. As more pathogenic strains develop resistance to existing drugs, the race for finding novel anti-bacterial and anti-fungal drugs becomes ever more urgent. The field of pathogenomics utilizes data acquired by genomics and related methods in order to better characterize pathogenic bacteria and fungi, interactions between different strains, and interactions between the pathogen and the human host. Pathogenomics has already been invaluable in understanding pathogenic evolution and diversity, in characterizing novel virulence factors, and in paving the way towards designing new diagnostic tests and drugs that will help keep humankind abreast of ever-changing pathogens.


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [2 Associated PubMed Articles listed on BioPortfolio]

IslandViewer 4: expanded prediction of genomic islands for larger-scale datasets.

IslandViewer (http://www.pathogenomics.sfu.ca/islandviewer/) is a widely-used webserver for the prediction and interactive visualization of genomic islands (GIs, regions of probable horizontal origin)...

Comparative pathogenomics of Clostridium tetani.

Clostridium tetani and Clostridium botulinum produce two of the most potent neurotoxins known, tetanus neurotoxin and botulinum neurotoxin, respectively. Extensive biochemical and genetic investigatio...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ERA-NET PathoGenoMics

Pathogen infections are among the leading causes for disease and mortality throughout the globe. As more pathogenic strains develop resistance to existing drugs, the race for find...

Infect-ERA

Infect-ERA, a consortium funded under the Seventh Framework programme (FP7), is a continuation of the former ERA-NET PathoGenoMics. To date, it includes 14 partners from 11...

More Information about "ERA-NET PathoGenoMics" on BioPortfolio

We have published hundreds of ERA-NET PathoGenoMics news stories on BioPortfolio along with dozens of ERA-NET PathoGenoMics Clinical Trials and PubMed Articles about ERA-NET PathoGenoMics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ERA-NET PathoGenoMics Companies in our database. You can also find out about relevant ERA-NET PathoGenoMics Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record